Organovo Holdings Inc (ONVO)
1.17
+0.02
(+1.74%)
USD |
NASDAQ |
Apr 17, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Price to Book Value: 1.900 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 16, 2024 | 1.868 |
April 15, 2024 | 2.192 |
April 12, 2024 | 1.640 |
April 11, 2024 | 1.673 |
April 10, 2024 | 1.673 |
April 09, 2024 | 1.702 |
April 08, 2024 | 1.689 |
April 05, 2024 | 1.657 |
April 04, 2024 | 1.705 |
April 03, 2024 | 1.673 |
April 02, 2024 | 1.673 |
April 01, 2024 | 1.673 |
March 28, 2024 | 1.673 |
March 27, 2024 | 1.640 |
March 26, 2024 | 1.705 |
March 25, 2024 | 1.673 |
March 22, 2024 | 1.657 |
March 21, 2024 | 1.673 |
March 20, 2024 | 1.673 |
March 19, 2024 | 1.705 |
March 18, 2024 | 1.803 |
March 15, 2024 | 1.705 |
March 14, 2024 | 1.608 |
March 13, 2024 | 1.640 |
March 12, 2024 | 1.640 |
Date | Value |
---|---|
March 11, 2024 | 1.640 |
March 08, 2024 | 1.657 |
March 07, 2024 | 1.640 |
March 06, 2024 | 1.657 |
March 05, 2024 | 1.673 |
March 04, 2024 | 1.673 |
March 01, 2024 | 1.657 |
February 29, 2024 | 1.657 |
February 28, 2024 | 1.640 |
February 27, 2024 | 1.592 |
February 26, 2024 | 1.601 |
February 23, 2024 | 1.624 |
February 22, 2024 | 1.640 |
February 21, 2024 | 1.624 |
February 20, 2024 | 1.671 |
February 16, 2024 | 1.657 |
February 15, 2024 | 1.657 |
February 14, 2024 | 1.722 |
February 13, 2024 | 1.640 |
February 12, 2024 | 1.819 |
February 09, 2024 | 1.462 |
February 08, 2024 | 1.624 |
February 07, 2024 | 1.575 |
February 06, 2024 | 1.681 |
February 05, 2024 | 1.657 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4913
Minimum
Dec 29 2022
7.442
Maximum
Feb 11 2021
1.690
Average
1.475
Median
Price to Book Value Benchmarks
CEL-SCI Corp | 6.443 |
AIM ImmunoTech Inc | 2.566 |
IGC Pharma Inc | 4.147 |
NovaBay Pharmaceuticals Inc | 1.812 |
Protalix BioTherapeutics Inc | 2.481 |
Price to Book Value Related Metrics
PEG Ratio | -0.0087 |
Price | 1.17 |
Earnings Yield | -185.5% |
Market Cap | 11.75M |
PEGY Ratio | -0.0087 |